FDA Approved: BEOVU — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved BEOVU (brolucizumab) under an original application from Novartis Pharmaceuticals Corporation for the treatment of neovascular age-related macul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• BEOVU (BROLUCIZUMAB)

Snippet

ORIG AP for BEOVU (BROLUCIZUMAB)